SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BriaCell and BriaPro to Present Preclinical Findings at SITC 2026

BriaCell and its majority-owned subsidiary BriaPro plan to present preclinical anti-cancer activity and immunotherapy findings at SITC 2026.

BCT

Related stories